Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2017.1360313
Abstract: We acknowledge that older data were used in our model, which can be explained by the fact that we finalized the model inputs before the 2014 CDC statistics were published. The updated age and sex… read more here.
Keywords: daclatasvir; daclatasvir sofosbuvir; reply cost; cost effectiveness ... See more keywords
Letter to the Editor, The Authors Reply: "Cost and Utility of Thrombophilia Testing".
Sign Up to like & getrecommendations! Published in 2017 at "Journal of hospital medicine"
DOI: 10.12788/jhm.2822
Abstract: We thank Dr. Berse and colleagues for their correspondence about our paper. We are pleased they agreed with our conclusion: Thrombophilia testing has limited clinical utility in most inpatient settings. read more here.
Keywords: utility; authors reply; reply cost; thrombophilia testing ... See more keywords